Regenerative medicine

Regenerative medicine is a core area of longevity research that focuses on the restoration and renewal of damaged tissues and organs. In contrast to conventional therapeutic approaches that merely treat symptoms, regenerative medicine aims to repair the underlying damage caused by the ageing process. This ability to regenerate tissues and organs could be the key to extending lifespan and maintaining health in old age.

  • One of the most promising technologies in regenerative medicine is stem cell therapy. Stem cells have the potential to differentiate into any type of cell and thus replace damaged tissue. In longevity research, stem cells are used to treat degenerative diseases such as heart disease, osteoarthritis and neurodegenerative diseases. In particular, mesenchymal stem cells (MSCs), which are derived from bone marrow, adipose tissue or umbilical cord blood, have been shown to be effective in reducing inflammation and promoting tissue repair. These stem cells can be injected into damaged tissues, where they reduce inflammation, renew cells and restore organ function.
  • Another groundbreaking technology in regenerative medicine is 3D bioprinting, which makes it possible to grow tissue and organs in the laboratory. 3D bioprinters use a combination of stem cells and biological materials to recreate structures such as skin, bone and even complex organs such as the kidney. In the future, this could provide a solution to the organ shortage in transplants. In addition, these cultivated organs could be adapted to the patient to prevent rejection reactions.
  • Regenerative medicine is also working on tissue rejuvenation to reverse the biological ageing of cells. Senolytic therapies, which aim to remove senescent cells (i.e. ageing cells that no longer divide) from the body, have been shown to improve tissue repair and reduce age-related inflammation. By combining stem cells and senolytic therapies, regenerative medicine could not only slow down ageing, but actually achieve rejuvenating effects.
  • In the future, regenerative medicine could therefore not only be used to cure diseases, but also to actively prevent age-related loss of function and thus combat ageing at a cellular level. This offers enormous opportunities for extending lifespan and improving quality of life in old age.

Swiss radio and television

Schweizer Radio und Fernsehen (SRF) serves the public with a wide range of high-quality programs. The company promotes the free formation of opinion through comprehensive and factual information, conveys cultural values and provides education and entertainment for the public. With its main studios in Zurich, Basel and Berne and regional studios in Aarau, Chur, Lucerne and St. Gallen, SRF strengthens its roots in the broadcasting region. SRF also has a global network of 60 correspondents who gather information on the ground and provide first-hand background information and assessments. SRF is SRG's largest business unit, comprising a total of 17 radio and 7 television channels as well as supplementary websites and teletext services for four language regions. As a non-profit organization, SRG is financed around 75 percent by licence fees and around 25 percent by commercial revenues. It is politically and economically independent.